147.55
-6.41(-4.16%)
Currency In USD
Previous Close | 153.96 |
Open | 152.93 |
Day High | 153.32 |
Day Low | 147.04 |
52-Week High | 157.13 |
52-Week Low | 55.92 |
Volume | 228,594 |
Average Volume | 498,549 |
Market Cap | 4.71B |
PE | -47.29 |
EPS | -3.12 |
Moving Average 50 Days | 135.71 |
Moving Average 200 Days | 102.06 |
Change | -6.41 |
If you invested $1000 in iRhythm Technologies, Inc. (IRTC) since IPO date, it would be worth $5,664.11 as of July 01, 2025 at a share price of $147.55. Whereas If you bought $1000 worth of iRhythm Technologies, Inc. (IRTC) shares 5 years ago, it would be worth $1,286.74 as of July 01, 2025 at a share price of $147.55.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease
GlobeNewswire Inc.
Jun 23, 2025 12:30 PM GMT
Retrospective real-world analyses of patients with type 2 diabetes—some of whom also had chronic kidney disease—demonstrate cardiac arrhythmias present frequent and early, often preceding major cardiovascular events (MACE)SAN FRANCISCO, June 23, 202
iRhythm Technologies to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
May 21, 2025 8:45 PM GMT
SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management tea
iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection
GlobeNewswire Inc.
May 01, 2025 8:10 PM GMT
iRhythm Zio® Long-Term Continuous Monitoring (LTCM) system — commercially introduced in Japan as the Zio® ECG Recording and Analysis System — brings AI-powered, continuous, uninterrupted ECG monitoring for up to 14 days to JapanLaunch is timely amid